Bicycle Therapeutics to Present Immune Oncology CD137 Data on Multivalent and Tumor-targeted Bispecific Bicycles at Peptides Congress
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Apr 24, 2019--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic p…
